2022
DOI: 10.1007/s12975-022-01049-w
|View full text |Cite
|
Sign up to set email alerts
|

Genome-Wide Association Study of Intracranial Artery Stenosis Followed by Phenome-Wide Association Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…An increasing number of studies have been conducted on the genetic analysis of ICAS recently. [ 33 , 78 , 101 ] Although the genetic factors underlying ICAS remain to be elucidated, current research approaches have missed our papers related to this issue. Despite these limitations, the strength of this study is its comprehensive analysis of ICAS, an important cause of ischemic stroke.…”
Section: Discussionmentioning
confidence: 99%
“…An increasing number of studies have been conducted on the genetic analysis of ICAS recently. [ 33 , 78 , 101 ] Although the genetic factors underlying ICAS remain to be elucidated, current research approaches have missed our papers related to this issue. Despite these limitations, the strength of this study is its comprehensive analysis of ICAS, an important cause of ischemic stroke.…”
Section: Discussionmentioning
confidence: 99%
“…Since the introduction of PheWAS over a decade ago, it has become a powerful technique to study the association of genetic variants and phenotypic variations across human populations (Bastarache, et al, 2022; Denny, et al, 2010). A PubMed search in December 2023, using the search terms of “PheWAS” or “phenome-wide association” in Title/Abstract field, returned 679 publications, from only 3 publications in 2010 to 159 publications in 2023, conducted in many biobanks and countries, including All of Us (United States), UK Biobank, BioBank Japan, and many others (Dofuku, et al, 2023; Millwood, et al, 2016; Rao, et al, 2018; Schlueter, et al, 2023). PheWAS has been used to address different scientific objectives, such as refining results in conjunction with genome-wide association studies (GWAS), studying comorbidities and precision subsets of disease, and evaluating potential repurposing of medications and predicting adverse drug reactions (Bastarache, et al, 2022).…”
Section: Introductionmentioning
confidence: 99%